Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2021-04-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
事前认可意见
Board/Management Information Classification · 95% confidence The document is an independent directors' prior approval opinion regarding several company matters: 2021 related party transactions, reappointment of the 2021 financial audit firm, and adjustments to a non-public stock issuance plan. It references compliance with regulatory rules and company governance but does not contain actual financial statements or detailed financial data. The document is a formal opinion and approval statement by independent directors before board consideration, not a full audit report or annual report. It is also not a brief announcement or a certification letter but a governance-related approval document. Therefore, it fits best under Board/Management Information (MANG), as it concerns board-level approvals and governance matters related to management decisions and audit firm reappointment.
2021-04-22 Chinese
2021年财务预算报告
Regulatory Filings Classification · 70% confidence The document is titled '2021 年度财务预算报告' which translates to '2021 Annual Financial Budget Report'. It contains detailed budget assumptions, sales targets, and financial planning measures for the year 2021. The content is forward-looking and focuses on budget planning rather than actual financial results or audited statements. The document length is 1375 characters, which is relatively short and does not contain actual financial statements or performance data. It is not an announcement of a report but the budget report itself. Given the nature of the document as a financial budget report, it does not fit the categories of Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a regulatory filing or announcement. The closest fitting category is Regulatory Filings (RNS) as a fallback because there is no specific category for budget reports in the provided list. However, since it is a financial planning document and not a regulatory announcement, the best classification is Regulatory Filings (RNS) with moderate confidence due to the lack of a perfect match.
2021-04-22 Chinese
中信建投证券股份有限公司关于天康生物股份有限公司2020年度募集资金存放与使用的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities Co., Ltd. regarding the 2020 annual special verification opinion on the deposit and use of raised funds by Tiankang Biological Co., Ltd. It includes detailed financial figures about the raised funds, their usage, balances, regulatory compliance, and audit opinions from an accounting firm. The document references regulatory requirements and includes tables of financial data related to the raised funds. It is not a brief announcement or a certification letter but a substantive report on the use of raised funds for a specific fiscal year. This fits the definition of an Audit Report / Information (AR), as it is a standalone audit and verification report on the use of raised funds, not a full annual report or earnings release. The length and detail confirm it is not a mere announcement or regulatory filing. Therefore, the appropriate classification is AR with high confidence. FY 2020
2021-04-22 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 15th meeting of the 7th Board of Directors of Tian Kang Biological Co., Ltd. It includes approvals of various reports such as the 2020 Annual Report, Board Work Report, General Manager Work Report, Financial Statements, Profit Distribution Plan, Internal Control Self-Evaluation Report, and others. The document also mentions that these reports and related materials are disclosed on the official information disclosure website and newspapers, indicating that this document itself is a meeting resolution announcement rather than the full reports. The document is about board meeting decisions and approvals, which is characteristic of Board/Management Information filings. It is not the full Annual Report (10-K), nor is it a simple announcement of report publication (RPA), as it contains substantive meeting resolutions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (6800 characters) supports it being a detailed announcement rather than a brief notice.
2021-04-22 Chinese
独立董事2020年度述职报告-剡根强
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2020 Annual Report" for Tian Kang Biological Co., Ltd. It contains detailed statements from the independent director about their duties, attendance at board and shareholder meetings, opinions on various company matters including financial audits, related party transactions, internal controls, profit distribution, employee stock plans, and other governance issues for the year 2020. The content is a comprehensive report on the independent director's activities and opinions over the fiscal year, which is typical of a management or board-related report rather than a full annual financial report or audit report. It is not a transcript, earnings release, or a simple announcement. The document length (over 10,000 characters) and detailed content indicate it is a substantive report. Given the focus on board-level oversight and independent director duties, the best fitting category is Board/Management Information (MANG).
2021-04-22 Chinese
2020年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2020 年度董事会工作报告' which translates to '2020 Annual Board of Directors Work Report'. It contains detailed information about the company's board activities, audit committee work, remuneration committee, nomination committee, strategic committee, shareholder meetings, and future outlook including business plans and risk factors. The content is a comprehensive report on the board's work and company governance for the year 2020. It is not a brief announcement or a simple voting result, nor is it a transcript or a financial statement report like an annual report or interim report. The document focuses on the board's activities and governance, which fits the category of Board/Management Information (MANG). The length (8679 characters) and detailed content confirm it is a full report rather than a short announcement. Therefore, the appropriate classification is MANG with high confidence.
2021-04-22 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.